2 results
Approved WMOPending
Primary Objective • To determine whether ITCA 650 is non-inferior either to empagliflozin or to glimepiride in reducing glycosylated hemoglobin A1c (HbA1c) or weight in patients with T2D following 65 weeks of treatment. The non-inferiority margins…
Approved WMOPending
Main:The main objective is to explore the potential utility of MRCP+ and LMS in monitoring disease activity and early detection of worsening disease requiring endoscopic intervention. Secondary Objective(s): Assessment of mean, median, range and…